Clinical Trial Update: Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of semaglutide on clinical outcomes and metabolic inflammation in patients with psoriasis, obesity, and typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psoriasis
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Psoriasis (PsO), Obesity & Overweight | Phase 4 | Status: RECRUITING